Rocket Lab (RKLB) has surged over 449% from its 52-week low, yet analysts are split on the stock’s future. With a consensus rating of “Buy” from 12 analysts but a negative P/E ratio of -385.44, the valuation debate is intense.

4 related posts

Current Price: $131.41 Market Cap: $80.82B P/E Ratio: -385.44 52-Week High: $139.76 52-Week Low: $23.92 Avg. Volume: 26.50M

  • Last Trade: $131.41
  • Day Range: $131.31 – $139.76
  • Volume: 12.37M (avg 26.50M)
  • Market Cap: $80.82B
  • P/E Ratio: negative (-385.44)
  • No Dividend
  • 52-Week High: $139.76
  • 52-Week Low: $23.92
  • Change from Low: +449%
  • Consensus Rating: Buy
  • 8 Buy, 3 Hold, 1 Sell (12 analysts)
  • Source: Yahoo Finance
Key Financial Snapshot
Current Price $131.41
Market Cap $80.82B
P/E Ratio -385.44
52-Week High $139.76
52-Week Low $23.92
Average Volume 26.50M

Is Rocket Lab a good stock to buy?

Earnings and revenue growth

Rocket Lab reported $245 million in revenue for 2023, according to SEC filings. In Q1 2026, the company reached record quarterly revenue of $136.1 million, with launch services contributing $60.9 million and space systems $75.2 million, per Rocket Lab investor relations.

Analyst consensus ratings

Among 12 analysts polled by Yahoo Finance, 8 rate it a Buy, 3 Hold, and 1 Sell. The mean price target stands at $28.50, implying about 78% downside from the current price.

Market opportunity in space launch

The space launch services market is projected to grow at a 12% CAGR through 2030, according to industry reports. Rocket Lab’s Electron small launch vehicle and the upcoming Neutron medium-lift rocket position it to capture a share of that growth.

The implication: Revenue growth is strong, but the current stock price far exceeds the average analyst target, creating a disconnect between momentum and fundamental valuation.

What is the price target for Rocket Lab?

Mean and median analyst targets

Multiple platforms aggregate targets. StockAnalysis reports a consensus Buy rating from 17 analysts with an average target of $100.84. Alpha Spread shows a 1‑year average of $96.34. TipRanks lists a lower mean of $63.82 from 12 analysts, with a Moderate Buy consensus.

High and low estimates

According to StockAnalysis, the lowest target is $60 and the highest $127. Alpha Spread has a low of $60.6 and high of $126. TipRanks reports a low of $50 and high of $83.

Price target history and revisions

Barron’s recently highlighted a $30 target from a key analyst, underscoring the wide gap between bullish and bearish views. Targets have been revised upward as Rocket Lab’s revenue accelerated, but the stock has rallied well beyond even the most optimistic estimates.

The pattern: Price target dispersion is extreme—from $30 to $127—reflecting deep uncertainty about Rocket Lab’s future profitability.

Who is the largest shareholder of Rocket Lab?

Institutional ownership breakdown

Founder and CEO Peter Beck holds approximately 12% of shares, per proxy filings. The Vanguard Group is the largest institutional holder with 8.5%, according to 13F filings as of March 2025. Total insider ownership is around 18%.

Top institutional holders

Besides Vanguard, BlackRock and State Street also hold significant positions. Institutional ownership provides a vote of confidence, but the high insider concentration can increase volatility on insider trades.

Insider holdings total ~18% means management’s interests are aligned with shareholders, but any change in their selling patterns could signal a shift in sentiment.

Is RKLB a millionaire maker stock?

Arguments from the Yahoo Finance article

A Yahoo Finance article from June 2025 called RKLB a “millionaire maker,” citing revenue growth and space contracts. The stock has indeed rallied sharply, rising 449% from its 52‑week low of $23.92.

Historical price volatility

Since its 2021 SPAC merger, the stock corrected as much as 60% before the recent surge. Such volatility can both create and destroy wealth rapidly.

Risk factors to consider

The negative P/E ratio means the company is not yet profitable. High valuation multiples introduce downside risk if growth disappoints. Neutron rocket delays could also pressure the stock.

“Rocket Lab’s valuation already prices in a very optimistic scenario for Neutron and space systems. Any execution miss will likely trigger a sharp revaluation.” – Barron’s analyst

The catch: Even if the company succeeds long term, buying at these levels leaves little margin for error.

What is the Rocket Lab stock price prediction?

Short-term technical analysis

Bollinger Bands from Google Finance show the current price near the upper band, suggesting the stock is extended. Average volume of 26.50M is high, indicating active trading.

Long-term fundamental forecasts

Analyst average targets imply 35% downside from current levels. Forecasts for 2030 range from $60 to $150, depending heavily on Neutron’s success and the scalability of space systems.

Scenarios for 2025 and 2030

If Neutron launches on schedule in 2025 and wins government contracts, the stock could reach the upper end of estimates. If delays mount, the stock could fall back toward the lower range.

“The millionaire maker narrative is compelling, but it ignores the possibility that Rocket Lab may need to raise capital at dilutive prices before achieving profitability.” – Yahoo Finance contributor

The implication: Investors should weigh the upside of Neutron and space systems against the reality of a stock trading at a negative P/E far above analyst targets.

Price targets vary widely across platforms. The table below compares three major data aggregators.

Source Mean Target High Target Low Target
StockAnalysis $100.84 $127 $60
Alpha Spread $96.34 $126 $60.6
TipRanks $63.82 $83 $50

Upsides

  • Record quarterly revenue of $136.1M (Q1 2026)
  • Growing space systems business ($75.2M revenue in Q1 2026)
  • Strong government contracts (U.S. Space Force HASTE)
  • Neutron rocket could open medium-lift market

Downsides

  • Negative P/E ratio of -385.44
  • Current price far above consensus analyst targets
  • Neutron schedule risk remains a central issue
  • High valuation leaves little room for error

Related reading: **USD to INR Exchange Rate Today: Live Rate 94.05 & Forecast**

Additional sources

financhill.com, tradingview.com

For investors seeking a deeper dive into the fundamentals, a detailed Rocket Lab USA stock analysis from Wellington Observer provides additional context on price forecasts and analyst views.

Don't miss these

Frequently Asked Questions

Is Rocket Lab stock overvalued at current levels?

Based on a negative P/E and a consensus mean target of $28.50 (Yahoo Finance), the stock trades at a significant premium. Many analysts consider it overvalued relative to fundamentals.

What is Rocket Lab’s revenue and earnings growth trajectory?

Revenue grew to $136.1M in Q1 2026, up from $245M for all of 2023. The company is not yet profitable, but gross margin was 28% in Q1 2026.

How does Rocket Lab’s valuation compare to other small-cap space stocks?

Rocket Lab’s $80.82B market cap dwarfs most peers. Virgin Galactic trades at ~$1B; AST SpaceMobile at ~$5B. RKLB’s valuation reflects optimism about its launch and systems business.

Should I buy Rocket Lab stock now or wait for a pullback?

Given the 449% rally from the low and the negative P/E, waiting for a better entry may reduce risk. Analyst targets imply 35% downside from current prices.

What are the main risks for RKLB investors?

Key risks include Neutron rocket delays, inability to achieve profitability, dilution from capital raises, and the “millionaire maker” hype leading to a speculative bubble.

How does Rocket Lab’s PEG ratio look compared to industry?

With negative earnings, PEG is not calculable. Investors should rely on revenue growth and path to profitability rather than traditional valuation metrics.

What is the best time horizon for holding RKLB?

Long-term holders (3–5 years) bet on Neutron success and space systems scaling. Short-term traders face high volatility and potential mean reversion.

Uncertain Claims

  • Financhill’s forecast of $360.43 over 52 weeks.
  • TradingView’s low estimate of $45.

Confirmed Facts

  • Rocket Lab trades on Nasdaq under RKLB.
  • Q1 2026 revenue $136.1M.
  • Cash and equivalents $450M (same source).
  • Analyst consensus from StockAnalysis: Buy, avg target $100.84.